Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Feb 17;300(6722):447–449. doi: 10.1136/bmj.300.6722.447

HIV testing in patients with end stage renal disease.

A Stevens 1, J Little 1, S Kerr 1, P Kilbane 1, C Doherty 1
PMCID: PMC1662216  PMID: 2107901

Abstract

One hundred and twenty eight British and Irish nephrologists were questioned about their policy for HIV testing of patients with end stage renal failure being considered for renal replacement therapy. A total of 101 (79%) replied. In the case of candidates for dialysis roughly one third of respondents tested only people they considered at risk of infection with HIV and nearly one fifth considered testing unnecessary. In the case of candidates for transplantation routine HIV testing was carried out by 68 of 100 nephrologists; 22 tested only patients "at risk" and 10 did not test. A positive HIV test result was considered by most but not all respondents (63/86) to exclude patients from transplantation. Twenty four of 88 nephrologists considered that HIV positivity should exclude patients from haemodialysis, but only seven of 87 would exclude such patients from peritoneal dialysis. Similar attitudes pertained for patients with end stage renal failure who refused HIV testing. Testing with the patient's knowledge and consent was the policy of two thirds of nephrologists, but a patient's signature was obtained by only 24 of 88. There should be a consensus on practice for HIV testing of patients with end stage renal failure.

Full text

PDF
447

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. C., Gorgone B. C., Marlink R. G., Ferriani R., Essex M. E., Benz P. M., Groopman J. E. Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons. Ann Intern Med. 1986 Oct;105(4):519–527. doi: 10.7326/0003-4819-105-4-519. [DOI] [PubMed] [Google Scholar]
  2. Assogba U., Park R. A., Rey M. A., Barthelemy A., Rottembourg J., Gluckman J. C. Prospective study of HIV I seropositive patients in hemodialysis centers. Clin Nephrol. 1988 Jun;29(6):312–314. [PubMed] [Google Scholar]
  3. Baillod R. A., Lui S. F., Sweny P., Ross M. G., Griffiths P. D., Grundy J., Moorhead J. F. Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Br Med J (Clin Res Ed) 1986 Sep 27;293(6550):819–819. doi: 10.1136/bmj.293.6550.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Challah S., Wing A. J., Bauer R., Morris R. W., Schroeder S. A. Negative selection of patients for dialysis and transplantation in the United Kingdom. Br Med J (Clin Res Ed) 1984 Apr 14;288(6424):1119–1122. doi: 10.1136/bmj.288.6424.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chirgwin K., Rao T. K., Landesman S. H., Friedman E. A. High seroprevalence of antibodies to human immunodeficiency virus in a Brooklyn maintenance hemodialysis unit: preliminary observations. ASAIO Trans. 1988 Jul-Sep;34(3):194–195. [PubMed] [Google Scholar]
  6. Dummer J. S., Erb S., Breinig M. K., Ho M., Rinaldo C. R., Jr, Gupta P., Ragni M. V., Tzakis A., Makowka L., Van Thiel D. Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation. 1989 Jan;47(1):134–140. doi: 10.1097/00007890-198901000-00030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Keidan A. J., Franklin I. M., Pinching A. J. Testing for HIV: the non-medicolegal view. Br Med J (Clin Res Ed) 1988 Jan 23;296(6617):288–288. doi: 10.1136/bmj.296.6617.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ortiz C., Meneses R., Jaffe D., Fernandez J. A., Perez G., Bourgoignie J. J. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int. 1988 Aug;34(2):248–253. doi: 10.1038/ki.1988.172. [DOI] [PubMed] [Google Scholar]
  9. Perez G. O., Ortiz C., De Medina M., Schiff E., Bourgoignie J. J. Lack of transmission of human immunodeficiency virus in chronic hemodialysis patients. Am J Nephrol. 1988;8(2):123–126. doi: 10.1159/000167570. [DOI] [PubMed] [Google Scholar]
  10. Rodger R. S., Tapson J. S., Codd A. A. Markers of HTLV-III in patients with end stage renal failure. Br Med J (Clin Res Ed) 1986 Aug 30;293(6546):565–565. doi: 10.1136/bmj.293.6546.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sherer R. Physician use of the HIV antibody test. The need for consent, counseling, confidentiality, and caution. JAMA. 1988 Jan 8;259(2):264–265. [PubMed] [Google Scholar]
  12. Sherrard M., Gatt I. Human immunodeficiency virus (HIV) antibody testing. Guidance from an opinion provided for the British Medical Association. Br Med J (Clin Res Ed) 1987 Oct 10;295(6603):911–912. doi: 10.1136/bmj.295.6603.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Weiss R., Thier S. O. HIV testing is the answer--what's the question? N Engl J Med. 1988 Oct 13;319(15):1010–1012. doi: 10.1056/NEJM198810133191509. [DOI] [PubMed] [Google Scholar]
  14. Williams P. F., Swan B., Cunningham K. Continuous ambulatory peritoneal dialysis fluid: another fluid positive for HIV antibody. Br Med J (Clin Res Ed) 1986 Oct 4;293(6551):885–885. doi: 10.1136/bmj.293.6551.885. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES